Clinical Trial Update: An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients With Gastric Cancer [Phase 2]

View source ↗

Summary

Open-label Phase 2 trial evaluating lenvatinib with pembrolizumab or lenvatinib with pembrolizumab and FLOT as neoadjuvant/adjuvant therapy for gastric cancer; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Eloxatin (oxaliplatin)
• KEYTRUDA (PEMBROLIZUMAB)
• LENVIMA (lenvatinib)
• Leucovorin (folinic acid)
• Taxotere (docetaxel)

Snippet

Sponsor: National Cancer Center Hospital East | Conditions: Gastric Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING